Tempus AI Inc. to Report Q2 2024 Financial Results on August 6

Curated by THEOUTPOST

On Wed, 17 Jul, 4:04 PM UTC

2 Sources

Share

Tempus AI Inc., a leading AI-driven precision medicine company, has announced that it will release its second quarter 2024 financial results on August 6, 2023. The company will also host a conference call to discuss the results and provide a business update.

Upcoming Financial Report

Tempus AI Inc., a prominent artificial intelligence-driven precision medicine company, has announced its plans to release the financial results for the second quarter of 2024 on Sunday, August 6, 2023 12. This announcement has caught the attention of investors and industry analysts alike, as it provides an opportunity to gauge the company's performance and future prospects.

Conference Call Details

In conjunction with the release of the financial results, Tempus will be hosting a conference call and live audio webcast 1. The call is scheduled to take place on Monday, August 7, 2023, at 8:00 a.m. Eastern Time (ET) 2. This timing allows investors and interested parties to review the results before the market opens, potentially influencing trading decisions for the day.

Accessing the Conference Call

For those interested in participating in the conference call, Tempus has provided multiple ways to access the event:

  1. Toll-Free Dial-In: 1-877-704-4453
  2. International Dial-In: 1-201-389-0920
  3. Conference ID: 13739753 12

These options ensure that both domestic and international participants can easily join the call and stay informed about the company's performance.

Webcast Information

For those who prefer a visual component or cannot join via phone, Tempus will also be providing a live audio webcast of the conference call 1. The webcast will be accessible through the company's investor relations website at investors.tempus.com, under the "Events and Presentations" section 2.

Replay Availability

Understanding that not all interested parties may be able to join the live call, Tempus has arranged for a replay of the conference call to be available. The replay can be accessed by calling 1-844-512-2921 (US) or 1-412-317-6671 (International) and using the replay pin number 13739753 12. This replay will be available until August 14, 2023, at 11:59 p.m. ET, giving ample time for review.

Significance of the Announcement

This announcement is significant for several reasons:

  1. It demonstrates Tempus's commitment to transparency and regular communication with its investors and the public.
  2. The financial results will provide insights into the company's performance in the rapidly evolving field of AI-driven precision medicine.
  3. The conference call offers an opportunity for analysts and investors to ask questions directly to the management team, potentially revealing more about the company's strategies and future outlook.

As the date approaches, market watchers will be keen to see how Tempus AI Inc. has performed in the second quarter and what this might indicate about the broader AI and healthcare technology sectors.

Continue Reading
Tempus AI Reports Strong Q4 2024 Results, Showcasing Growth

Tempus AI Reports Strong Q4 2024 Results, Showcasing Growth in AI-Driven Healthcare

Tempus AI, Inc. (NASDAQ:TEM) released its Q4 2024 financial results, demonstrating significant progress in AI-powered healthcare solutions. The earnings call highlighted the company's achievements and future strategies.

Seeking Alpha logo

2 Sources

Seeking Alpha logo

2 Sources

Tempus AI Stock Soars on Collaboration with Follicular

Tempus AI Stock Soars on Collaboration with Follicular Lymphoma Institute, Attracts Major Institutional Investors

Tempus AI's stock reaches an all-time high following a collaboration announcement with the Institute for Follicular Lymphoma Innovation. The company's AI-driven approach to precision medicine attracts significant investments from major funds.

Benzinga logoInvestopedia logo

4 Sources

Benzinga logoInvestopedia logo

4 Sources

Tempus AI Stock Soars 108% in 2025 Amid Mixed Q4 Earnings

Tempus AI Stock Soars 108% in 2025 Amid Mixed Q4 Earnings and Future Prospects

Tempus AI, an AI-driven healthcare company, sees its stock price surge 108% in 2025 despite mixed Q4 earnings. The company's future looks promising but faces challenges in profitability and market expectations.

The Motley Fool logoSeeking Alpha logoBenzinga logoInvestopedia logo

8 Sources

The Motley Fool logoSeeking Alpha logoBenzinga logoInvestopedia logo

8 Sources

Tempus AI Executives Sell Shares Amid Strategic

Tempus AI Executives Sell Shares Amid Strategic Acquisitions and FDA Clearance

Multiple Tempus AI executives sell shares for tax purposes as the company makes strategic moves in genomics and AI-driven healthcare, receives FDA clearance for a new device, and faces analyst scrutiny.

Investing.com UK logo

6 Sources

Investing.com UK logo

6 Sources

Tempus AI Unveils Immune Profile Score Test and Presents

Tempus AI Unveils Immune Profile Score Test and Presents Research at SITC 2024

Tempus AI, Inc. announces the clinical launch of its Immune Profile Score (IPS) algorithmic test and the acceptance of nine abstracts for presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting, showcasing advancements in AI-driven precision medicine for cancer treatment.

Market Screener logoInvesting.com UK logo

3 Sources

Market Screener logoInvesting.com UK logo

3 Sources

TheOutpost.ai

Your one-stop AI hub

The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.

© 2025 TheOutpost.AI All rights reserved